October 19, 2011
Cancer is a class of diseases characterized by out-of-control cell growth. Lung cancer occurs when this uncontrolled cell growth begins in one or both lungs. Rather than developing into healthy, normal lung tissue, these abnormal cells continue dividing and form lumps or masses of tissue called tumours. Tumours interfere with the main function of the lung, which is to provide the bloodstream with oxygen to be carried to the entire body. If a tumour stays in one spot and demonstrates limited growth, it is generally considered to be benign. http://www.bharatbook.com/detail.asp?id=214711&rt=Lung-Cancer-Drug-Market.html
More dangerous, or malignant, tumours form when the cancer cells migrate to other parts of the body through the blood or lymph system. When a tumour successfully spreads to other parts of the body and grows, invading and destroying other healthy tissues, it is said to have metastasized. This process itself is called metastasis, and the result is a more serious condition that is very difficult to treat. ” market research reports ”
Lung cancer is called “primary” if the cancer originates in the lungs and “secondary” if it originates elsewhere in the body but has metastasized to the lungs. These two types are considered different cancers from diagnostic and treatment perspectives.
Lung cancer can be broadly classified into two main types based on the cancer’s appearance under a microscope: non-small cell lung cancer and small cell lung cancer. Non-small cell lung cancer (NSCLC) accounts for 80% of lung cancers, while small cell lung cancer accounts for the remaining 20%.
Table of Contents :
Prescribed Class of Drugs
Age Adjusted Rate
Spread of Lung Cancer
Market Estimation and Forecasting
For more information kindly visit :
Contact us at :
Bharat Book Bureau
Tel: +91 22 27578668 / +91 22 27579438
Fax: +91 22 27579131
Follow us on twitter: http://twitter.com/#!/Sandhya3B